サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427983

そう痒症治療薬の世界市場レポート 2024

Pruritus Therapeutics Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
そう痒症治療薬の世界市場レポート 2024
出版日: 2024年02月14日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

そう痒症治療薬の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.6%の年間複合成長率（CAGR）で149億9,000万米ドルに成長すると予想されます。予測期間中に予測される拡大は、そう痒症の病態生理学に対するより広範な理解、製剤および送達方法の進歩、個別化医療への注目、皮膚科学の研究開発の急増、意識と診断率の高まり、関心の高まりに関連している可能性があります。予測期間中に予想される注目すべき動向には、かゆみ特異的受容体アゴニストおよびアンタゴニストの開発、個別化された治療アプローチへの市場の重点、かゆみの監視と管理における技術の統合、および学際的な調査のための共同努力が含まれます。

そう痒症治療薬市場は、皮膚疾患の発生率の増加により成長が見込まれています。皮膚疾患には、座瘡、湿疹、皮膚がん、真菌感染症など、皮膚、毛髪、爪、粘膜に影響を及ぼすさまざまな状態が含まれます。かゆみの治療法は、局所治療、皮膚軟化剤、免疫抑制剤、特定のかゆみの薬など、かゆみの根本的な原因によって決定されることがよくあります。米国がん協会の報告書によると、2020年から2021年にかけて皮膚がんの症例数は5.8%増加し、108,480件に達したことが明らかになりました。この皮膚疾患の急増がそう痒症治療薬市場の成長の原動力となっています。

世界の高齢者人口の増加は、眼科インプラント市場の拡大に寄与すると予想されます。 65歳以上の高齢者を含む高齢者は、加齢に伴うさまざまな要因により、そう痒症になりやすくなっています。世界保健機関によると、世界の60歳以上の人口は、2020年の10億人から2022年までに14億人に達すると予測されています。高齢化社会の特有のニーズにより、かゆみの懸念に対処するためにそう痒症治療薬が重要になります。世界の高齢者人口の増加により、そう痒症治療薬市場の成長が促進される見込みです。特に、フランスに拠点を置くバイオ医薬品会社イプセンは、2023年11月にメディソン・ファーマと協力して、生後6か月以上の進行性家族性肝内胆汁うっ滞（PFIC）患者を対象とした革新的なそう痒症治療薬「ビルベイ」を開発しました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のそう痒症治療薬市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のそう痒症治療薬市場規模実績と成長、2018年から2023年
  • 世界のそう痒症治療薬市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のそう痒症治療薬市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • コルチコステロイド
  • 抗ヒスタミン薬
  • 局所麻酔薬
  • 反刺激物質
  • 免疫抑制剤
  • カルシニューリン阻害剤
  • その他の製品
  • 世界のそう痒症治療薬市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • オーラル
  • 非経口
  • 話題
  • 世界のそう痒症治療薬市場、疾患タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • アトピー性皮膚炎
  • アレルギー性接触皮膚炎
  • 蕁麻疹
  • 皮膚T細胞
  • 他の種類の病気
  • 世界のそう痒症治療薬市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • クリニック
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界のそう痒症治療薬市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のそう痒症治療薬市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • そう痒症治療薬市場の競合情勢
  • そう痒症治療薬市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • AbbVie Inc.
    • Sanofi SA
    • Bristol-Myers Squibb Company

第31章 その他の大手および革新的な企業

  • Abbott Laboratories
  • Eli Lilly and Company
  • Amgen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Astellas Pharma Inc.
  • Bausch Health Companies Inc.
  • Brunswick Corporation
  • Galderma Laboratories LP
  • Cipla Limited
  • Vifor Pharma Ltd.
  • Carl Zeiss Meditec AG
  • LEO Pharma AS
  • Mirum Pharmaceuticals Inc.
  • Cara Therapeutics Inc.
  • GlaxoSmithKline Plc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13827

Pruritus therapeutics pertains to the treatments employed to alleviate an uncomfortable skin sensation prompting a desire to scratch. This approach is commonly applied to alleviate swelling and inflammation in moderate-to-severe inflammatory skin conditions.

The primary product categories of pruritus therapeutics encompass corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressants, calcineurin inhibitors, and others. Corticosteroids denote synthetic anti-inflammatory medications utilized to address itching and inflammation resulting from pruritus. These medications can be administered through various routes, including oral, parenteral, and topical, aiding in the treatment of diverse disease types such as atopic dermatitis, allergic contact dermatitis, urticaria, cutaneous T-cell, among others. They find application in hospitals, clinics, and other medical settings.

The pruritus therapeutics research market report is one of a series of new reports from The Business Research Company that provides pruritus therapeutics market statistics, including pruritus therapeutics industry global market size, regional shares, competitors with a pruritus therapeutics market share, detailed pruritus therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the pruritus therapeutics industry. This pruritus therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pruritus therapeutics market size has grown strongly in recent years. It will grow from $11.39 billion in 2023 to $12.03 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The increase observed during the historical period can be ascribed to a rise in the incidence of pruritus, a variety of causes and conditions, the growing aging population, and a heightened focus on improving patient quality of life.

The pruritus therapeutics market size is expected to see strong growth in the next few years. It will grow to $14.99 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The expansion projected for the forecast period can be linked to the broader understanding of pruritus pathophysiology, advancements in drug formulations and delivery methods, a spotlight on personalized medicine, a surge in dermatological research and development, heightened awareness and diagnosis rates, and an increasing interest in botanical and herbal remedies. Noteworthy trends anticipated during the forecast period encompass the development of itch-specific receptor agonists and antagonists, a market emphasis on personalized therapeutic approaches, the integration of technology in itch monitoring and management, and collaborative efforts for cross-disciplinary research.

The pruritus therapeutics market is anticipated to witness growth due to the increasing incidence of dermatological disorders. Dermatological disorders encompass a range of conditions affecting the skin, hair, nails, and mucous membranes, including acne, eczema, skin cancer, and fungal infections. The use of pruritus treatments is often determined by the underlying cause of itching, involving topical treatments, emollients, immunosuppressant medications, and specific itching medications. A report by the American Cancer Society Inc. revealed a 5.8% increase in skin cancer cases from 2020 to 2021, reaching 108,480 cases. This surge in dermatological disorders is a driving force behind the growth of the pruritus therapeutics market.

The global increase in the geriatric population is expected to contribute to the expansion of the ocular implant market. The geriatric population, comprising individuals aged 65 and older, is more susceptible to pruritus due to various factors associated with aging. According to the World Health Organization, the global population of individuals aged 60 and above is projected to reach 1.4 billion by 2022, compared to 1 billion in 2020. The aging population's specific needs make pruritus therapeutics crucial in addressing itching concerns. The rise in the geriatric population worldwide is poised to drive the growth of the pruritus therapeutics market. Notably, Ipsen, a France-based biopharmaceutical company, collaborated with Medison Pharma in November 2023 to develop an innovative pruritus treatment, Bylvay, for patients aged 6 months or older with Progressive Familial Intrahepatic Cholestasis (PFIC).

A prominent trend in the pruritus therapeutics market is product innovation, with major companies focusing on developing novel treatments to strengthen their market position. For instance, in August 2021, Fresenius Medical Care AG & Co., a Germany-based provider for people with kidney illnesses, launched KORSUVA (difelikefalin) for reducing pruritus related to chronic kidney dysfunction in adults undergoing hemodialysis. This therapeutic injectable drug, approved by the FDA, is a first-in-class kappa opioid receptor (KOR) targeting the outer neurological system. Product innovation remains a key strategy for companies aiming to enhance the safety and effectiveness of pruritus treatments.

Leading companies in the pruritus therapeutics market are concentrating on the development of oral solutions for managing cholestatic pruritus in patients with Alagille syndrome (ALGS) aged one year and older. An oral solution for cholestatic pruritus is a liquid medication designed to alleviate itching associated with liver conditions. In September 2021, Mirum Pharmaceuticals, Inc., a US-based biotechnology company, received FDA approval for LIVMARLI (maralixibat) oral solution to manage cholestatic pruritus in individuals aged one year and older with ALGS. The company's Mirum Access Plus (MAP) program provides access to LIVMARLI, offering support services, insurance coverage, and financial assistance through dedicated coordinators.

In March 2023, Ipsen, the France-based biopharmaceutical company, acquired Albireo Pharma, Inc., a US-based clinical-stage biopharmaceutical company. This strategic acquisition aims to expand Ipsen's portfolio by incorporating promising medicines for pediatric and adult uncommon cholestatic liver disorders. Albireo Pharma, Inc., specializes in oral drugs, including the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC). The acquisition enriches Ipsen's capabilities with unique pipeline potential and scientific and commercial expertise.

Major companies operating in the pruritus therapeutics market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Eli Lilly and Company, Amgen Inc. , Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Brunswick Corporation, Galderma Laboratories LP, Cipla Limited, Vifor Pharma Ltd., Carl Zeiss Meditec AG, LEO Pharma AS, Mirum Pharmaceuticals Inc., Cara Therapeutics Inc., GlaxoSmithKline PLC, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

North America was the largest region in the pruritus treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pruritus therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pruritus therapeutics market consists of revenues earned by entities by providing topical therapy, phototherapy, and systemic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The pruritus therapeutics market also include sales of hydroxyzine, benadryl, banophen, diphedryl, and allermax. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pruritus Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pruritus therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pruritus therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pruritus therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Corticosteroids; Antihistamines; Local Anesthetics; Counterirritants; Immunosuppressants; Calcineurin Inhibitors; Other Products
  • 2) By Route of Administration: Oral; Parenteral; Topical
  • 3) By Disease Type: Atopic Dermatitis; Allergic Contact Dermatitis; Urticaria; Cutaneous T-Cell; Other Disease Types
  • 4) By End-User: Hospitals; Clinics; Other End Users
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Sanofi S.A.; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pruritus Therapeutics Market Characteristics

3. Pruritus Therapeutics Market Trends And Strategies

4. Pruritus Therapeutics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Pruritus Therapeutics Market Size and Growth

  • 5.1. Global Pruritus Therapeutics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Pruritus Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Pruritus Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pruritus Therapeutics Market Segmentation

  • 6.1. Global Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Corticosteroids
  • Antihistamines
  • Local Anesthetics
  • Counterirritants
  • Immunosuppressant
  • Calcineurin Inhibitors
  • Other Products
  • 6.2. Global Pruritus Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Topical
  • 6.3. Global Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Atopic Dermatitis
  • Allergic Contact Dermatitis
  • Urticaria
  • Cutaneous T-Cell
  • Other Disease Types
  • 6.4. Global Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Other End Users

7. Pruritus Therapeutics Market Regional And Country Analysis

  • 7.1. Global Pruritus Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Pruritus Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pruritus Therapeutics Market

  • 8.1. Asia-Pacific Pruritus Therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pruritus Therapeutics Market

  • 9.1. China Pruritus Therapeutics Market Overview
  • 9.2. China Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pruritus Therapeutics Market

  • 10.1. India Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pruritus Therapeutics Market

  • 11.1. Japan Pruritus Therapeutics Market Overview
  • 11.2. Japan Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pruritus Therapeutics Market

  • 12.1. Australia Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pruritus Therapeutics Market

  • 13.1. Indonesia Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pruritus Therapeutics Market

  • 14.1. South Korea Pruritus Therapeutics Market Overview
  • 14.2. South Korea Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pruritus Therapeutics Market

  • 15.1. Western Europe Pruritus Therapeutics Market Overview
  • 15.2. Western Europe Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pruritus Therapeutics Market

  • 16.1. UK Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pruritus Therapeutics Market

  • 17.1. Germany Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pruritus Therapeutics Market

  • 18.1. France Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pruritus Therapeutics Market

  • 19.1. Italy Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pruritus Therapeutics Market

  • 20.1. Spain Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pruritus Therapeutics Market

  • 21.1. Eastern Europe Pruritus Therapeutics Market Overview
  • 21.2. Eastern Europe Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pruritus Therapeutics Market

  • 22.1. Russia Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pruritus Therapeutics Market

  • 23.1. North America Pruritus Therapeutics Market Overview
  • 23.2. North America Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pruritus Therapeutics Market

  • 24.1. USA Pruritus Therapeutics Market Overview
  • 24.2. USA Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pruritus Therapeutics Market

  • 25.1. Canada Pruritus Therapeutics Market Overview
  • 25.2. Canada Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pruritus Therapeutics Market

  • 26.1. South America Pruritus Therapeutics Market Overview
  • 26.2. South America Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pruritus Therapeutics Market

  • 27.1. Brazil Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pruritus Therapeutics Market

  • 28.1. Middle East Pruritus Therapeutics Market Overview
  • 28.2. Middle East Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pruritus Therapeutics Market

  • 29.1. Africa Pruritus Therapeutics Market Overview
  • 29.2. Africa Pruritus Therapeutics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Pruritus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Pruritus Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pruritus Therapeutics Market Competitive Landscape And Company Profiles

  • 30.1. Pruritus Therapeutics Market Competitive Landscape
  • 30.2. Pruritus Therapeutics Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi S.A.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Pruritus Therapeutics Market Other Major And Innovative Companies

  • 31.1. Abbott Laboratories
  • 31.2. Eli Lilly and Company
  • 31.3. Amgen Inc.
  • 31.4. Regeneron Pharmaceuticals Inc.
  • 31.5. Astellas Pharma Inc.
  • 31.6. Bausch Health Companies Inc.
  • 31.7. Brunswick Corporation
  • 31.8. Galderma Laboratories LP
  • 31.9. Cipla Limited
  • 31.10. Vifor Pharma Ltd.
  • 31.11. Carl Zeiss Meditec AG
  • 31.12. LEO Pharma AS
  • 31.13. Mirum Pharmaceuticals Inc.
  • 31.14. Cara Therapeutics Inc.
  • 31.15. GlaxoSmithKline Plc

32. Global Pruritus Therapeutics Market Competitive Benchmarking

33. Global Pruritus Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pruritus Therapeutics Market

35. Pruritus Therapeutics Market Future Outlook and Potential Analysis

  • 35.1 Pruritus Therapeutics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Pruritus Therapeutics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Pruritus Therapeutics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer